Translating academic theory into tangible societal benefit is a core part for global higher education sector. For PolyU, the 2024/25 academic year has been nothing short of transformative. Generating HK$2.98 billion in total knowledge transfer income – a formidable 42.6% year-on-year increase – the University has firmly cemented its position as the second-leading university in Hong Kong for both knowledge transfer and research patent applications.

PolyU’s rapid growth in a single year is driven by its relentless and targeted commitment to commercialising pioneering basic research. In the 2024/25 academic year, the University’s research patent applications surged by nearly 40% to an impressive 554, claiming the runner-up spot citywide. Simultaneously, trial and express licensing skyrocketed by 152%.

Accelerating high-impact innovation

These metrics are not merely administrative victories; they represent life-changing technologies entering the public domain. From developing the critical ground validation system for the Nation’s historic lunar far-side sampling missions to rolling out commercialised spectacle lenses that effectively halt childhood myopia, PolyU is bridging the gap between the laboratory and real life.

A significant driver of the success has been a strategic pivot towards high-impact sectors: artificial intelligence (AI), medical engineering and sustainability. Researchers have unveiled AI-integrated diagnostic tools for liver fibrosis and ophthalmology, AI-driven fire forecasting systems and smart textiles for health monitoring. In the realm of sustainable infrastructure, new energy-saving coatings and high-performance steel are setting modern industry standards.

Forging strategic global partnerships

Crucially, PolyU has not achieved this in a silo. The University’s achievement is underpinned by an aggressive expansion of strategic partnerships. Deepening its medical-engineering ties, PolyU has forged partnerships with global and regional key players, including Stanford Medicine, Peking University Third Hospital, the National University Regional Center for Technology Transfer in Biomedicine, and Suzhou Kowloon Hospital.

Corporate collaborations with industry leaders such as Huawei Cloud, China Railway and China Tower have further combined academic with commercial enterprise. This collaborative network is supported by 44 university-level research centres and an expanding roster of Mainland Translational Research Institutes and Mainland Translational Research Centres, designed to provide vital industry support.

Cultivating a thriving start-up ecosystem

The core of PolyU’s commercialisation strategy is, however, its vibrant entrepreneurial ecosystem. The University’s flagship PolyVentures ecosystem helps nurture the next-generation of entrepreneurs and advance innovative ideas and cutting-edge solutions that drive positive societal impact through various funding schemes, incubation facilities and business mentorship, contributing to the betterment of Hong Kong, the Nation, and the world.

Bolstered by 67 international awards and a strong 54th position in the QS World University Rankings 2026, PolyU’s trajectory is clear. By resolutely championing the journey from fundamental laboratory research to pragmatic life-enhancing applications, PolyU has not only secured its elite standing in Hong Kong but also established a remarkable blueprint for the future of global academic enterprise.

Click here to read the full report.